KRRO-110 is the first RNA editing development candidate from Korro’s proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...

Students will explore the effects of venoms, poisons, drugs and everyday chemicals on the human body, receiving expert-level instruction and hands-on training at the college’s Arizona Poison and Drug ...

Tracking targeted drug delivery is often a challenge due to limitations in the current imaging techniques. A recent study reports a breakthrough imaging technique that allows direct and highly ...

Researchers from the University of Colorado Anschutz Medical Campus studied a new method to deliver antibiotics, specifically gentamicin, directly into the bladder tissue to better treat UTIs. They ...

Tracking targeted drug delivery is often a challenge due to limitations in current imaging techniques. A recent study by ...

The immune system typically can ramp up the body's defenses to clear out an invading threat without issue. Glitches can happen, however, with sepsis occurring when the mustered army of cells also ...

A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have uncovered a powerful combination therapy leveraging sotorasib-an FDA-approved ...

A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have ...

Duke pharmacology and cancer biology professor Donald McDonnell estimates his laboratory has received up to $40 million in ...

On November 5, 2024, Adial announced the appointment of Vinay Shah as the Company’s Chief Financial Officer. Mr. Shah is an accomplished Chief Financial Officer with over 25 years of experience in the ...

MIRA Pharmaceuticals gains approval for a Phase 1 trial of Ketamir-2 in Israel, aiming to complete by Q4 2025 before moving ...